Results 171 to 178 of about 826 (178)

The Case for Physiologically Based Biopharmaceutics Modelling (PBBM): What do Dissolution Scientists Need to Know?

Dissolution Technologies, 2020
Vivian A. Gray, James C. Mann, Richard Barker, Xavier J. H. Pepin   +3 more
openaire   +1 more source

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Journal of Pharmaceutical Sciences, 2018
Steven Castleberry, Daniel A J Bow
exaly  

Physiologically-Based Biopharmaceutics Modeling in Support of Drug Product Specifications and Biowaiver

Xavier Pepin, Fang Wu, Tycho Heimbach, Filippos Kesisoglou, Haritha Mandula, Rodrigo Cristofoletti, Sandra Suarez   +6 more
openaire   +1 more source

Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies

Journal of Pharmaceutical Sciences, 2019
Christophe Tistaert, Tycho Heimbach, Binfeng Xia   +2 more
exaly  

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat

European Journal of Pharmaceutical Sciences
Maria Vertzoni, Sebastian Frechen, Michaela Meyer   +2 more
exaly  

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat

European Journal of Pharmaceutical Sciences
Maria Vertzoni, Sebastian Frechen, Michaela Meyer   +2 more
exaly  

Physiologically based biopharmaceutics modeling to predict bioequivalence of rivaroxaban formulated as conventional tablets, OD tablets, and fine granules

Journal of Drug Delivery Science and Technology
Atsushi Kambayashi
exaly  

Food Effect in Pediatric Populations: Current Practice, Challenges, and Future Potential for Use of Physiologically Based Biopharmaceutics Modeling

The Journal of Clinical Pharmacology
openaire   +2 more sources